Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Karl Hsu

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cancer Cell|September 6, 2003
Turning on a dimer: new insights into MLL chimerasKarl Hsu, A Thomas Look
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-based therapy for solid tumorsLi Yan, Karl Hsu, Robert A Beckman
British Journal of Haematology|November 18, 2003
Zebrafish as a model organism for blood diseasesJason Berman, Karl Hsu, A Thomas Look
Methods in Cell Biology|December 18, 2004
Lessons from transgenic zebrafish expressing the green fluorescent protein (GFP) in the myeloid lineageKarl Hsu, A Thomas Look, John P Kanki
Blood Cancer Journal|March 31, 2019
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myelomaThomas Martin, Stephen Strickland, Martha Glenn, et al.
Biotechniques|August 25, 2005
Making waves in cancer research: new models in the zebrafishStephane Berghmans, Cicely Jette, David Langenau, et al.
Developmental Cell|December 29, 2004
Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafishJennifer Rhodes, Andreas Hagen, Karl Hsu, et al.
Experimental Hematology|January 30, 2007
Dominant-interfering C/EBPalpha stimulates primitive erythropoiesis in zebrafishTing Xi Liu, Jennifer Rhodes, Min Deng, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Developmental Cell|December 12, 2003
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosisTing Xi Liu, Niall G Howlett, Min Deng, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cancer Cell|September 6, 2003
Turning on a dimer: new insights into MLL chimerasKarl Hsu, A Thomas Look
Cancer Journal (Sudbury, Mass.)|June 10, 2008
Antibody-based therapy for solid tumorsLi Yan, Karl Hsu, Robert A Beckman
British Journal of Haematology|November 18, 2003
Zebrafish as a model organism for blood diseasesJason Berman, Karl Hsu, A Thomas Look
Methods in Cell Biology|December 18, 2004
Lessons from transgenic zebrafish expressing the green fluorescent protein (GFP) in the myeloid lineageKarl Hsu, A Thomas Look, John P Kanki
Blood Cancer Journal|March 31, 2019
Phase I trial of isatuximab monotherapy in the treatment of refractory multiple myelomaThomas Martin, Stephen Strickland, Martha Glenn, et al.
Biotechniques|August 25, 2005
Making waves in cancer research: new models in the zebrafishStephane Berghmans, Cicely Jette, David Langenau, et al.
Developmental Cell|December 29, 2004
Interplay of pu.1 and gata1 determines myelo-erythroid progenitor cell fate in zebrafishJennifer Rhodes, Andreas Hagen, Karl Hsu, et al.
Experimental Hematology|January 30, 2007
Dominant-interfering C/EBPalpha stimulates primitive erythropoiesis in zebrafishTing Xi Liu, Jennifer Rhodes, Min Deng, et al.
Investigational New Drugs|March 23, 2011
A phase I trial of MK-0731, a kinesin spindle protein (KSP) inhibitor, in patients with solid tumorsKyle Holen, Robert DiPaola, Glenn Liu, et al.
Developmental Cell|December 12, 2003
Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosisTing Xi Liu, Niall G Howlett, Min Deng, et al.
Pageof 3